Dukon Medical Showcases Advanced Neuromodulation Suite at the 23rd Shenzhen International Rehabilitation Forum

Dukon Medical presents its flagship non-invasive brain stimulation suite and multi-scenario rehabilitation solutions at Shenzhen’s premier clinical summit.

SHENZHEN, China — August 22, 2026 — On August 21, 2026, Shijiazhuang Dukon Medical Instruments Co., Ltd. presented its non-invasive brain neuromodulation technology suite at the 23rd Shenzhen International Rehabilitation Forum. The delegation, led by Vice General Manager Li Zhichao, engaged with prominent clinical experts, scholars, and industry representatives to discuss technological translation and clinical application strategies in modern neurorehabilitation.

Advancing Non-Invasive Neuromodulation in Clinical Practice
As neurorehabilitation transitions toward precision, multidisciplinary care, and non-invasive interventions, brain stimulation technologies have become central to functional recovery. At the forum, Dukon Medical showcased its flagship non-invasive neuromodulation portfolio, designed for cognitive, motor, and psychiatric rehabilitation:

Repetitive Transcranial Magnetic Stimulation (rTMS) Systems: Supporting high- and low-frequency targeted cortical stimulation.

Transcranial Electrical Stimulation (tES/tDCS) Devices: Delivering portable, precise constant-current stimulation.

Transcranial Ultrasonic Electrotherapy Devices: Combining acoustic and electrical modalities for deep-tissue neural modulation.

Brain Reflex & EEG Therapy Systems: Integrating diagnostic monitoring with therapeutic feedback.

Clinical specialists at the conference highlighted the operational efficacy and application scenarios of Dukon’s rTMS devices in hospital settings, noting their role in accelerating neural pathway reconstruction for stroke and psychiatric recovery.

Bridging Academic Research and Frontline Rehabilitation
Throughout the event, Vice General Manager Li Zhichao and Dukon technical representatives held technical exchanges with senior rehabilitation specialists. Discussions focused on addressing frontline clinical challenges, optimizing device user interfaces, and expanding treatment protocols across inpatient and outpatient care.

"True medical device innovation must directly serve frontline clinicians and patients," noted Vice General Manager Li Zhichao during discussions. "Engaging directly with clinical leaders allows us to refine our product architecture based on real-world treatment demands."

Strategic Expansion Across Six Core Clinical Units
Dukon Medical demonstrated its evolution from an equipment manufacturer to a provider of multi-scenario rehabilitation solutions. The company outlined its technical integration across six specialized units:

Neurological Rehabilitation: Targeted motor and cognitive restoration.

Mental Health Rehabilitation: Non-pharmacological protocols for depression, anxiety, and sleep disorders.

Pediatric Rehabilitation: Child-friendly non-invasive stimulation for developmental care.

Traditional Chinese Medicine (TCM) Integrated Rehab: Combining physical therapy with traditional wellness principles.

Critical Care (ICU) Rehabilitation: Early-stage functional maintenance for severe care units.

Home-Care Rehabilitation: Portable, safe devices extending hospital-grade care to home environments.

By connecting hospital-grade equipment with primary healthcare facilities and home recovery setups, Dukon aims to establish a continuous, long-term care ecosystem for patients transitioning out of clinical environments.

Key Event Highlights
Event: The 23rd Shenzhen International Rehabilitation Forum (2026)

Date & Location: August 21, 2026 | Shenzhen, Guangdong Province, China

Core Focus: Non-invasive brain neuromodulation (rTMS, tDCS, Transcranial Ultrasonic Electrotherapy) and integrated multi-scenario rehabilitation solutions.

Key Delegation: Vice General Manager Li Zhichao and Dukon Medical technical directors.